全球静脉铁剂药物市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、增长、趋势和预测

全球静脉铁剂市场需求预计将从 2022 年的 58.3 亿美元增至 2030 年的近 413.3 亿美元，2023-2030 年研究期间复合年增长率为 24.31%。

静脉补铁药物是通过将一根细管插入手臂静脉并註射含铁的液体溶液来将铁输送到体内的过程。这些药物优于口服补充剂，因为它们可以更快更快地提高铁和血红蛋白水平。这些药物的其他好处包括增加能量水平和更轻鬆的呼吸。

市场动态

慢性肾病和贫血的发病率不断上升可能有助于该市场的增长。由于从口服含铁药物向静脉注射含铁药物的转变，市场需求也在上升。此外，全球炎症性肠病（IBD）和癌症病例的增加增加了对静脉铁剂药物的需求，预计这将推动市场增长。由于研发活动的增加，对静脉铁剂药物的需求不断增长，推动了全球静脉铁剂药物市场的增长。此外，人们对贫血诊断和治疗的认识不断提高，预计将在预测期内扩大市场增长。然而，高昂的治疗成本可能会限制该市场的增长。

该研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球静脉铁剂药物市场的各个细分市场进行了包容性评估。静脉铁剂药物行业的增长和趋势为本研究提供了整体方法。

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲静脉铁药物市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。静脉铁剂药物市场的主要参与者包括Vifor Pharma Management Ltd.、AMAG Pharmaceuticals、Daiichi Sankyo Company, Ltd.（American Regent. Inc.）、Sanofi SA、Pharmacosmos A/S、Shield Therapeutics Plc、AbbVie Inc.（Allergan ）有限公司）。本节包含竞争格局的整体视图，包括各种战略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何定制要求，请写信给我们。我们的研究团队可以根据您的需求提供定制报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市场亮点
• 全球市场概况

第 3 章：静脉铁剂药物 - 行业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 行业动态
• 波特五力分析
• 市场吸引力分析
  • 按产品分類的市场吸引力分析
  • 市场吸引力分析：按应用分类
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原材料分析
  • 原材料清单
  • 原料厂商清单
  • 主要原材料价格走势
• 潜在买家名单
• 营销渠道
  • 直效行销
  • 间接营销
  • 营销渠道发展趋势

第 5 章：COVID-19 爆发的影响分析

第 6 章：全球静脉铁药市场分析：按产品分类

• 按产品概述
• 历史和预测数据
• 按产品分析
• 右旋糖酐铁
• 蔗糖铁
• 羧基麦芽糖铁
• 其他的

第 7 章：全球静脉铁剂市场分析：按应用分类

• 概述：按应用
• 历史和预测数据
• 分析：按应用
• 慢性肾病
• 炎症性肠病
• 癌症
• 其他的

第 8 章：全球静脉铁剂市场分析：按地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概述、历史和预测销售分析
  • 北美按细分市场销售分析
  • 北美按国家/地区销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概述、历史和预测销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家/地区销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 意大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概述、历史和预测销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳大利亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概述、历史和预测销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家/地区销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概述、历史和预测销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙特阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 9 章：静脉铁剂药物公司的竞争格局

• 静脉铁剂药物市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 10 章：公司简介

• 顶级公司市场份额分析
• 市场集中度
• Vifor Pharma Management Ltd.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• AMAG Pharmaceuticals
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Daiichi Sankyo Company Ltd. (American Regent. Inc.)
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Sanofi SA
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Pharmacosmos A/S
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Shield Therapeutics Plc
• 公司简介
• 公司收入
• 产品
• 最近的发展
• AbbVie Inc. (Allergan Plc)
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细信息和近期发展视情况而定，或者如果是私营公司，则可能不包括在内

The global demand for Intravenous Iron Drugs Market is presumed to reach the market size of nearly USD 41.33 BN by 2030 from USD 5.83 BN in 2022 with a CAGR of 24.31% under the study period 2023 - 2030.

Intravenous iron drug supplementation is the process of delivering iron to the body by inserting a tiny tube into the vein of the arm and administering a liquid solution containing iron. These drugs are superior to oral supplements as they increase the iron and Hb levels higher and faster. Other benefits of these drugs include increased energy levels and easier breathing.

MARKET DYNAMICS

The growing incidences of chronic kidney diseases & anaemia may contribute to the growth of this market. The demand for the market is also rising due to the shifting trend from oral ferrous drugs to intravenous ferrous drugs. Moreover, increasing cases of inflammatory bowel disease (IBD) and cancer worldwide have increased demand for intravenous iron drugs, which is expected to drive market growth. The growing demand for intravenous iron drugs due to the rising research & development activities is fueling the global intravenous iron drugs market growth. Also, the increasing awareness of the diagnosis and treatment of anaemia is expected to scale up the market growth during the forecast period. However, the high cost of treatment may limit the growth of this market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of intravenous iron drugs. The growth and trends of intravenous iron drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the intravenous iron drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Iron Dextran
• Iron Sucrose
• Ferric Carboxymaltose
• Others

By Application

• Chronic Kidney Disease
• Inflammatory Bowel Disease
• Cancer
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Intravenous Iron Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the intravenous iron drugs market include Vifor Pharma Management Ltd., AMAG Pharmaceuticals, Daiichi Sankyo Company, Ltd. (American Regent. Inc.), Sanofi S.A., Pharmacosmos A/S, Shield Therapeutics Plc, AbbVie Inc. (Allergan Plc). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . INTRAVENOUS IRON DRUGS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL INTRAVENOUS IRON DRUGS MARKET ANALYSIS BY PRODUCT

• 6.1 Overview by Product
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Product
• 6.4 Iron Dextran Historic and Forecast Sales by Regions
• 6.5 Iron Sucrose Historic and Forecast Sales by Regions
• 6.6 Ferric Carboxymaltose Historic and Forecast Sales by Regions
• 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL INTRAVENOUS IRON DRUGS MARKET ANALYSIS BY APPLICATION

• 7.1 Overview by Application
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Application
• 7.4 Chronic Kidney Disease Historic and Forecast Sales by Regions
• 7.5 Inflammatory Bowel Disease Historic and Forecast Sales by Regions
• 7.6 Cancer Historic and Forecast Sales by Regions
• 7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL INTRAVENOUS IRON DRUGS MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE INTRAVENOUS IRON DRUGS COMPANIES

• 9.1. Intravenous Iron Drugs Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF INTRAVENOUS IRON DRUGS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Vifor Pharma Management Ltd.
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. AMAG Pharmaceuticals
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Daiichi Sankyo Company Ltd. (American Regent. Inc.)
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Sanofi S.A.
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. Pharmacosmos A/S
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Shield Therapeutics Plc
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. AbbVie Inc. (Allergan Plc)
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Product (USD MN)
• Iron Dextran Market Sales by Geography (USD MN)
• Iron Sucrose Market Sales by Geography (USD MN)
• Ferric Carboxymaltose Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis Market by Application (USD MN)
• Chronic Kidney Disease Market Sales by Geography (USD MN)
• Inflammatory Bowel Disease Market Sales by Geography (USD MN)
• Cancer Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Intravenous Iron Drugs Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Intravenous Iron Drugs Report
• Market Research Process
• Market Research Methodology
• Global Intravenous Iron Drugs Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Product
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Product (USD MN)
• Iron Dextran Market Sales by Geography (USD MN)
• Iron Sucrose Market Sales by Geography (USD MN)
• Ferric Carboxymaltose Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by Application (USD MN)
• Chronic Kidney Disease Market Sales by Geography (USD MN)
• Inflammatory Bowel Disease Market Sales by Geography (USD MN)
• Cancer Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.